Social Media

Hematologist and Oncologist, Director, Amyloidosis Center @amyloidosis_bu. Hematologist and Oncologist @The_BMC

Supporting patients and families while promoting research, education and awareness.

Cardiologist at Mayo Clinic. Former junior #Musketeer. #amyloidosis and #echo. Tweets limited to medicine and #Xavier basketball. My own and not my employer's.

Eidos Therapeutics, a subsidiary of BridgeBio Pharma, is developing AG10 as a targeted therapeutic for transthyretin amyloidosis. The company's singular mission is…

Dr. Suzanne Lentzsch, MD, PhD. Director of the Multiple Myeloma and Amyloidosis Service at Columbia University Medical Center.

Nephros is a commercial stage medical device company that develops and sells high-performance liquid purification filters. Nephros filters capture contaminants as…

Stanford IM residency program director, Cardiologist, Specialist in Amyloidosis, Cardio-Oncology, and Advanced heart failure.

BSIM's mission is to deliver quality drug candidates with high capital efficiency against transthyretin-mediated amyloidosis, including clinical manifestations and…

Twitter Handle: Director, Cardiac Amyloidosis Program, Brigham and Women's Hospital and Harvard Medical School.

SOM Biotech is a clinical-stage drug discovery and development company based in Barcelona, Spain, with an office in the US, focused on repurposing drugs for CNS…